Skip to content

Observation on the rehabilitation effect of hyperbaric oxygen combined with respiratory training on stroke related obstructive sleep apnea

Observation on the rehabilitation effect of hyperbaric oxygen combined with respiratory training on stroke related obstructive sleep apnea

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2300073967
Enrollment
Unknown
Registered
2023-07-26
Start date
2023-07-27
Completion date
Unknown
Last updated
2023-07-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

stroke-related obstructive sleep apnea

Interventions

1:Give routine stroke treatment and secondary prevention measures, non breathing training and Hyperbaric medicine
2:On the basis of the first group, respiratory training treatment was conducted simultaneously for a total of 80 days, with a weekly training period of 5 days from Monday to Friday and a rest period o
3:On the basis of the second group, Hyperbaric medicine was added. The time of daily Hyperbaric medicine was staggered from the time of respiratory training, and respiratory training was not allowed i

Sponsors

Jiangwan Hospital in Hongkou District, Shanghai
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: ?Aged 18 to 80 years old; ?Conform to the diagnostic criteria of hemorrhagic and ischemic stroke in the "Key Points for Diagnosis of Major Cerebrovascular Diseases in China 2019", and have been diagnosed with cerebral infarction by computed tomography (CT) or magnetic resonance imaging (MRI) stroke patients; ? No severe cognitive impairment or speech impairment, stable vital signs, and can cooperate to complete relevant examinations; ? Diagnosed as OSA by polysomnography (PSG); ? Sign the informed consent

Exclusion criteria

Exclusion criteria: ?Patients with structural abnormalities in the face, oropharynx, and neck; ?Patients with advanced stroke and unstable condition; ?Those with serious heart, liver, kidney, lung and other medical diseases; ?Patients with severe sleep disorders or continuous positive pressure ventilation in the past; ? Patients with other neurological diseases such as intracranial space occupation and infection in the past; ? People with severe cognitive impairment; ? Long-term use of sleeping pills or other psychotropic drugs.

Design outcomes

Primary

MeasureTime frame
polysomnography(PSG) related data;Montreal Cognitive Assessment,MoCA;Mini-Mental State Exam,MMSE;Hamilton Anxiety Scale,HAMA;Hamilton Depression Scale,HAMD;National Institutes of Health Stroke Scale,NIHSS;Pittsburgh sleep quality index,PSQI;The Epworth Sleeping Scale,ESS;blood gas analysis;homocysteine,Hcy;

Countries

China

Contacts

Public ContactBai Jie

Jiangwan Hospital in Hongkou District, Shanghai

15621520642@163.com+86 183 2152 1886

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026